The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model

Genetic Vaccines and Therapy

Volumn 7, Issue , 2009, Pages

  Lai, Ming Derg ^a,b   Yen, Meng Chi ^a   Lin, Chiu Mei ^c,d   Tu, Cheng Fen ^a   Wang, Chun Chin ^e   Lin, Pei Shan ^e   Yang, Huei Jiun ^a   Lin, Chi Chen ^e,f  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR DNA VACCINE; GOLD; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; FEMALE; GENE GUN; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; LUNG CANCER; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; XENOGRAFT;

ANIMALIA; MUS;

EID: 61849158296     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-7-2     Document Type: Article

References (28)

1. Zandi R Larsen AB Andersen P Stockhausen MT Poulsen HS Mechanisms for oncogenic activation of the epidermal growth factor receptor Cell Signal 2007, 19:2013-23 17681753
2. Yarden Y The EGFR family and its ligands in human cancer: Signaling mechanisms and therapeutic opportunities Eur J Cancer 2001, 37:S3-8 11597398
3. Nicholson S Richard J Sainsbury C Halcrow P Kelly P Angus B Wright C Henry J Farndon JR Harris AL Epidermal growth factor receptor (EGFR); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup Br J Cancer 1991, 63:146-50 1846551
4. Lipponen P Eskelinen M Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprote in (c-erbB-2, p53) expression and long-term prognosis Br J Cancer 1994, 69:1120-5 7911031
5. Galizia G Lieto E Ferraraccio F De Vita F Castellano P Orditura M Imperatore V La Mura A La Manna G Pinto M Catalano G Pignatelli C Ciardiello F Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery Ann Surg Oncol 2006, 13:823-835 16614884
6. Mountain CF New prognostic factors in lung cancer: Biologic prophets of cancer cell aggression Chest 1995, 108:246-254 7606966
7. Schiff BA McMurphy AB Jasser SA Younes MN Doan D Yigitbasi OG Kim S Zhou G Mandal M Bekele BN Holsinger FC Sherman SI Yeung SC El-Naggar AK Myers JN Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer Clin Cancer Res 2004, 10:8594-8602 15623643
8. Dancey J Epidermal growth factor receptor inhibitors in clinical development Int J Radiat Oncol Biol Phys 2004, 58:1003-7 Review 14967462
9. Harari PM Epidermal growth factor receptor inhibition strategies in oncology Endocr Relat Cancer 2004, 11:689-708 15613446
10. Metro G Finocchiaro G Toschi L Bartolini S Magrini E Cancellieri A Trisolini R Castaldini L Tallini G Crino L Cappuzzo F Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC) Rev Recent Clin Trials 2006, 1:1-13 Review 18393776
11. Giaccone G HER1/EGFR-targeted agents: Predicting the future for patients with unpredictable outcomes to therapy Ann Onc 2005, 16:538-548 15746148
12. Huang SF Liu HP Li LH Ku YC Fu YN Tsai HY Chen YT Lin YF Chang WC Kuo HP Wu YC Chen YR Tsai SF High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan Clin Cancer Res 2004, 10:8195-203 15623594
13. Valentini AM Pirrelli M Caruso ML EGFR-targeted therapy in colorectal cancer: Does immunohistochemistry deserve a role in predicting the response to cetuximab? Curr Opin Mol Ther 2008, 10:124-31 18386224
14. Berzofsky JA Terabe M Oh S Belyakov IM Ahlers JD Janik JE Morris JC Progress on new vaccine strategies for the immunotherapy and prevention of cancer J Clin Invest 2004, 113:1515- 25 Review 419494 15173875
15. Choo AY Choo DK Kim JJ Weiner DB DNA vaccination in immunotherapy of cancer Cancer Treat Res 2005, 123:137-56 Review 16211869
16. Lin CC Chou CW Shiau AL Tu CF Ko TM Chen YL Yang BC Tao MH Lai MD Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu Mol Ther 2004, 10:290-301 15294176
17. Curcio C Di Carlo E Clynes R Smyth MJ Boggio K Quaglino E Spadaro M Colombo MP Amici A Lollini PL Musiani P Forni G Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas J Clin Invest 2003, 111:1161-70 152940 12697735
18. Lu Y Wei YQ Tian L Zhao X Yang L Hu B Kan B Wen YJ Liu F Deng HX Li J Mao YQ Lei S Huang MJ Peng F Jiang Y Zhou H Zhou LQ Luo F Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor J Immunol 2003, 170:3162-70 12626574
19. Pertmer TM Eisenbraun MD McCabe D Prayaga SK Fuller DH Haynes JR Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA Vaccine 1995, 13:1427-1430 8578820
20. Barry MA Johnston SA Biological features of genetic immunization Vaccine 1997, 15:788-791 9234514
21. Feltquate DM Heaney S Webster RG Robinson HL Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization J Immunol 1997, 158:2278-84 9036975
22. Lin CC Yen MC Lin CM Huang SS Yang HJ Chow NH Lai MD Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer J Gene Med 2008, 10:679-89 18324638
23. Duś D Budzyński W Radzikowski C LL2 cell line derived from transplantable murine Lewis lung carcinoma - maintenance in vitro and growth characteristics Arch Immunol Ther Exp (Warsz) 1985, 33:817-23 3833118
24. Wyatt LS Earl PL Eller LA Moss B Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge Proc Natl Acad Sci USA 2004, 101:4590-4595 384791 15070762
25. Robinson HL Torres CA DNA vaccine Semin Immunol 1997, 9:271-283 9327522
26. Condon C Watkins SC Celluzzi CM Thompson K Falo LD Jr DNA-based immunization by in vivo transfection of dendritic cells Nat Med 1996, 2:1122-1128 8837611
27. Boyle CM Morin M Webster RG Robinson HL Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein J Virol 1996, 70:9074-9078 191015 8971047
28. Winegar RA Monforte JA Suing KD O'Loughlin KG Rudd CJ MacGregor JT Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization Hum Gene Ther 1996, 7:2185-2194 8934232